« Back
Home /
Nintedanib (BIBF1120)

Nintedanib (BIBF1120)

Item no.	M1673-100mg
Manufacturer	AbMole
CASRN	656247-17-5
Amount	100mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Bladder Cancer
Type	Inhibitors
Specific against	other
Purity	>99%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Nintedanib
Similar products	BIBF1120, Vargatef
Available
Target Information	VEGFR/PDGFR
Molecular Weight	539, 62
Solubility	DMSO ≥ 20 mg/mL
Bioactivity information	Nintedanib (BIBF1120) is a novel triple angiokinase inhibitor of VEGFR, PDGFR and FGFR.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1673-100mg-safety-datasheet.pdf